Clover Health Investments, Corp. (NASDAQ:CLOV – Free Report) – Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for Clover Health Investments in a report issued on Sunday, March 2nd. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings of ($0.07) per share for the quarter, down from their previous estimate of ($0.03). The consensus estimate for Clover Health Investments’ current full-year earnings is ($0.12) per share. Leerink Partnrs also issued estimates for Clover Health Investments’ Q2 2025 earnings at $0.00 EPS, Q4 2025 earnings at ($0.13) EPS, FY2025 earnings at ($0.20) EPS, Q1 2026 earnings at ($0.05) EPS, Q2 2026 earnings at $0.03 EPS, Q3 2026 earnings at $0.02 EPS, Q4 2026 earnings at ($0.12) EPS, FY2026 earnings at ($0.12) EPS, FY2027 earnings at ($0.06) EPS, FY2028 earnings at $0.00 EPS and FY2029 earnings at $0.07 EPS.
Other research analysts have also issued reports about the stock. Canaccord Genuity Group raised their price objective on shares of Clover Health Investments from $4.20 to $4.50 and gave the stock a “buy” rating in a report on Monday. Craig Hallum began coverage on shares of Clover Health Investments in a report on Tuesday, December 17th. They set a “buy” rating and a $6.00 target price on the stock.
Clover Health Investments Stock Down 4.2 %
CLOV stock opened at $3.67 on Wednesday. Clover Health Investments has a 52-week low of $0.61 and a 52-week high of $4.87. The company has a market capitalization of $1.84 billion, a PE ratio of -18.35 and a beta of 2.00. The stock’s 50 day moving average is $4.08 and its two-hundred day moving average is $3.61.
Hedge Funds Weigh In On Clover Health Investments
Several hedge funds and other institutional investors have recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Clover Health Investments by 20.4% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 118,156 shares of the company’s stock valued at $333,000 after buying an additional 20,044 shares during the last quarter. Forum Financial Management LP boosted its stake in Clover Health Investments by 33.8% during the 3rd quarter. Forum Financial Management LP now owns 16,077 shares of the company’s stock valued at $45,000 after purchasing an additional 4,061 shares in the last quarter. Concurrent Investment Advisors LLC bought a new stake in shares of Clover Health Investments in the 3rd quarter worth $28,000. Sigma Planning Corp acquired a new position in Clover Health Investments during the third quarter worth about $29,000. Finally, KBC Group NV bought a new position in shares of Clover Health Investments during the 3rd quarter valued at about $53,000. Institutional investors and hedge funds own 19.77% of the company’s stock.
About Clover Health Investments
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Further Reading
- Five stocks we like better than Clover Health Investments
- What is the FTSE 100 index?
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- 3 REITs to Buy and Hold for the Long Term
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- 3 Healthcare Dividend Stocks to Buy
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.
